Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma

Figure 3 Expression patterns of the six lncRNAs in tumor and non-tumor tissues. Differential expression of RMST (A), EIF3J-AS1 (B), SERHL (C), PVT1 (D), MSC-AS1 (E), and POLR2J4 (F) between hepatocellular carcinoma and non-cancerous samples. G: The ROC curve of tumor tissue vs non-tumor tissue discriminated by the six-lncRNA signature. (H) Comparisons of the distribution of high-risk and low-risk patients in early stage (TNM I/II) and late stage (TNM III/IV) by the chi-square test.